Panacea Index Logo

Command Palette

Search for a command to run...

Women With Gestational Diabetes Mellitus Randomized to a Higher-Complex Carbohydrate/Low-Fat Diet Manifest Lower Adipose Tissue Insulin Resistance, Inflammation, Glucose, and Free Fatty Acids: A Pilot Study.

Diabetes care
January 1, 2016
Teri L Hernandez et al. (13 authors)
Journal ArticleRandomized Controlled TrialResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tHuman StudyClinical
Study Details

Study Goal

The researchers aimed to compare the effects of a higher-complex carbohydrate/lower-fat (CHOICE) diet versus a conventional low-carbohydrate/higher-fat (LC/CONV) diet on maternal insulin resistance, adipose tissue lipolysis, and infant adiposity in women with gestational diabetes mellitus (GDM).

Results Summary

The CHOICE diet improved maternal insulin resistance and reduced adipose tissue lipolysis and proinflammatory gene expression compared to the LC/CONV diet. Infant adiposity also trended lower with the CHOICE diet.

Population

Overweight/obese women with diet-controlled GDM.

Effective Dosage

CHOICE diet (60% carbohydrate/25% fat/15% protein) and LC/CONV diet (40% carbohydrate/45% fat/15% protein).

Duration

Approximately 7 weeks.

Interactions

None mentioned.

Extracted Claims (7)
InterventionDirectionEndpointPopulationDosageImpactClaim #
higher-complex carbohydrate/lower-fat (CHOICE) diet
decrease
fasting glucose
diet-controlled overweight/obese women with GDM
P = 0.03
decreased
#1
higher-complex carbohydrate/lower-fat (CHOICE) diet
decrease
free fatty acids
diet-controlled overweight/obese women with GDM
P = 0.06
decreased
#2
low-carbohydrate/higher-fat (LC/CONV) diet
increase
fasting glucose
diet-controlled overweight/obese women with GDM
P = 0.03
increased
#3
higher-complex carbohydrate/lower-fat (CHOICE) diet
increase
insulin suppression of AT lipolysis
diet-controlled overweight/obese women with GDM
56 vs. 31%, P = 0.005
improved
#4
higher-complex carbohydrate/lower-fat (CHOICE) diet
increase
insulin resistance
diet-controlled overweight/obese women with GDM
-
improved
#5
higher-complex carbohydrate/lower-fat (CHOICE) diet
decrease
AT expression of multiple proinflammatory genes
diet-controlled overweight/obese women with GDM
P < 0.01
lower
#6
higher-complex carbohydrate/lower-fat (CHOICE) diet
decrease
infant adiposity
-
10.1 ± 1.4 vs. 12.6 ± 2%
trended lower
#7
Abstract

OBJECTIVE: Diet therapy in gestational diabetes mellitus (GDM) has focused on carbohydrate restriction but is poorly substantiated. In this pilot randomized clinical trial, we challenged the conventional low-carbohydrate/higher-fat (LC/CONV) diet, hypothesizing that a higher-complex carbohydrate/lower-fat (CHOICE) diet would improve maternal insulin resistance (IR), adipose tissue (AT) lipolysis, and infant adiposity. RESEARCH DESIGN AND METHODS: At 31 weeks, 12 diet-controlled overweight/obese women with GDM were randomized to an isocaloric LC/CONV (40% carbohydrate/45% fat/15% protein; n = 6) or CHOICE (60%/25%/15%; n = 6) diet. All meals were provided. AT was biopsied at 37 weeks. RESULTS: After ∼7 weeks, fasting glucose (P = 0.03) and free fatty acids (P = 0.06) decreased on CHOICE, whereas fasting glucose increased on LC/CONV (P = 0.03). Insulin suppression of AT lipolysis was improved on CHOICE versus LC/CONV (56 vs. 31%, P = 0.005), consistent with improved IR. AT expression of multiple proinflammatory genes was lower on CHOICE (P < 0.01). Infant adiposity trended lower with CHOICE (10.1 ± 1.4 vs. 12.6 ± 2%, respectively). CONCLUSIONS: A CHOICE diet may improve maternal IR and infant adiposity, challenging recommendations for a LC/CONV diet.

Medical Subject Headings (MeSH)
Adipose TissueAdultBlood GlucoseDiabetes, GestationalDiet, DiabeticDiet, Fat-RestrictedFastingFatty Acids, NonesterifiedFemaleGlycemic IndexHumansInflammationInsulinInsulin ResistanceObesityOverweightPilot ProjectsPregnancyYoung Adult
Study Links
Quality Scores
SafetyNot Assessed
Efficacy85/10
Quality75/10
Citation Metrics
Total Citations112
Citations/Year12.4
Relative Citation Ratio5.13
NIH Percentile93.3%
Research Impact Scores
APT Score0.95
Weight Score2.02
Normalized Score0.69
Related Supplements